Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Di-Han LiuZe-Rui ZhaoHao Long Translational Research and Biomarkers 28 February 2019 Pages: 1934 - 1941
Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy Paolo Dell’OglioZhe TianPierre I. Karakiewicz Urologic Oncology 27 March 2019 Pages: 1942 - 1949
Response to: “Intact Excision of Breast Lesions Using BLES™: Is There a Clinical Indication Yet?” Pat Whitworth Breast Oncology 15 March 2019 Pages: 1950 - 1951
Letter to the Editor Regarding ‘What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort of 518 Patients’ J. V. VeldF. J. AmelungP. J. Tanis Gastrointestinal Oncology 07 March 2019 Pages: 1952 - 1953
Response to Dr. Veld et al. Regarding the Manuscript Titled “What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort of 518 patients” Diane MegeCharles SabbaghMehdi Karoui Colorectal Cancer 06 March 2019 Pages: 1954 - 1955